| P2093 | author name string | LeWitt PA | |
| | Damiano AM | |
| | Means ED | |
| | Willian MK | |
| | Reyes PF | |
| | McGrath MM | |
| | Richter RR | |
| | Snyder CF | |
| P2860 | cites work | Parkinsonism: onset, progression, and mortality | Q28259134 |
| | Adrenal medullary transplant to the striatum of patients with advanced Parkinson's disease: 1-year motor and psychomotor data | Q30570278 |
| | A review of health-related quality-of-life concepts and measures for Parkinson's disease | Q33725653 |
| | Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study | Q34396153 |
| | Quality of life in patients with Parkinson's disease: development of a questionnaire | Q36894428 |
| | Advances in methods for assessing the impact of epilepsy and antiepileptic drug therapy on patients' health-related quality of life | Q40989410 |
| | A controlled trial of piracetam in intellectually impaired patients with Parkinson's disease | Q44632887 |
| | Quality of life and Parkinson's disease: translation and validation of the US Parkinson's Disease Questionnaire (PDQ-39). | Q47704633 |
| | Quality of life in patients with Parkinson's disease who transfer from standard levodopa to Sinemet CR: the STAR Study. The STAR Multicenter Study Group | Q48797988 |
| | Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease. A multicenter 5-year study. The CR First Study Group. | Q50532825 |
| | Quality of life and Parkinson's disease: the CR FIRST Study. | Q51097255 |
| | The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. | Q52016073 |
| | Comparisons of the costs and quality of norms for the SF-36 health survey collected by mail versus telephone interview: results from a national survey. | Q52883840 |
| | Health-related quality of life in Parkinson's disease: a study of outpatient clinic attenders. | Q53587271 |
| | Comparison of standard carbidopa-levodopa and sustained-release carbidopa-levodopa in Parkinson's disease: pharmacokinetic and quality-of-life measures. | Q53590333 |
| | Self-reported functioning and well-being in patients with Parkinson's disease: comparison of the short-form health survey (SF-36) and the Parkinson's Disease Questionnaire (PDQ-39) | Q53635978 |
| | Self-reported health status and access to health services in a community sample with Parkinson's disease. | Q54529958 |
| | Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patients | Q64891702 |
| P433 | issue | 1 | |
| P921 | main subject | Parkinson's disease | Q11085 |
| | quality of life | Q13100823 |
| P304 | page(s) | 87-100 | |
| P577 | publication date | 2000-02-01 | |
| P1433 | published in | Quality of Life Research | Q15749950 |
| P1476 | title | Evaluation of a measurement strategy for Parkinson's disease: assessing patient health-related quality of life | |
| P478 | volume | 9 | |